113-00-8 = 865-47-4 [标题:Reaction Conditions 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
113-00-8 = 865-47-4 [标题:Reaction Conditions 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
105-56-6 = 865-47-4 [标题:Reaction Conditions 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
= 865-47-4 反应条件:1.1 Reagents: Sodium Hydride Solvents: Dimethyl Sulfoxide2.1 - 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
= 865-47-4 反应条件:1.1 Catalysts: Oxalyl Chloride2.1 - 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
= 865-47-4 反应条件:1.1 -2.1 Catalysts: Acetamide 标题:Structural Modifications Of The Potassium Channel Activator Cromakalim: The C-3 Position 作者:Buckle,Derek R.; Et Al 参考文献:Journal Of The Chemical Society 日期:1991 卷标:(1) 页码:63-72]
= 865-47-4 反应条件:1.1 Solvents: Ethanol2.1 Catalysts: Oxalyl Chloride3.1 - 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
= 865-47-4 反应条件:1.1 Reagents: Potassium; 50 °C 标题:A Practical Synthesis Of (Z)- And (E)-8-Dodecene-1-Yl Acetate,Components Of Lepidoptera Insect Sex Pheromones 作者:Ciotlaus,Irina; Et Al 参考文献:Revista De Chimie (Bucharest 日期:2017 卷标:68(1) 页码:157-162]
= 865-47-4 反应条件:1.1 Solvents: Acetonitrile,Water 标题:Structurally Simple Benzyl-Type Photolabile Protecting Groups For Direct Release Of Alcohols And Carboxylic Acids 作者:Wang,Pengfei; Et Al 参考文献:Organic Letters 日期:2015 卷标:17(9) 页码:2114-2117]
113-00-8 = 865-47-4 [标题:Reaction Conditions 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
113-00-8 = 865-47-4 [标题:Reaction Conditions 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
113-00-8 = 865-47-4 [标题:Reaction Conditions 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
= 865-47-4 反应条件:1.1 Catalysts: Acetamide 标题:Structural Modifications Of The Potassium Channel Activator Cromakalim: The C-3 Position 作者:Buckle,Derek R.; Et Al 参考文献:Journal Of The Chemical Society 日期:1991 卷标:(1) 页码:63-72]
= 865-47-4 反应条件:1.1 -2.1 Reagents: Sodium Hydride Solvents: Dimethyl Sulfoxide3.1 - 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
= 865-47-4 [标题:Reaction Conditions 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
= 865-47-4 反应条件:1.1 Solvents: Tetrahydrofuran2.1 -3.1 -4.1 - 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
= 865-47-4 反应条件:1.1 -2.1 Solvents: Ethanol3.1 Catalysts: Oxalyl Chloride4.1 - 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization]
= 865-47-4 反应条件:1.1 Reagents: Lithium Borohydride Solvents: Methanol2.1 -3.1 Reagents: Sodium Hydride Solvents: Dimethyl Sulfoxide4.1 - 标题:Preparation Of N-[4-[3-(2-Aminopyrido[2,3-D]Pyrimidin-6-Yl)Propyl]Benzoyl]Glutamates And Analogs As Antitumor Agents 参考文献:European Patent Organization
叔丁醇 在 氢化钾体系中,反应 3.0H,获得 Potassium Tert-Butylate 参考文献:新型萘并吡喃的合成及其光致变色性能 标题:新型萘并吡喃的合成及其光致变色性能 摘要:两个被苯基(13-丁基-6,7-二甲氧基-3,3-双(6-甲氧基联苯-3-基)-3,13-二氢苯并[ H ]茚满[2,1-F ]铬烯取代的新型异构萘并吡喃-13-Ol)和4-(萘-1-基)苯基(13-丁基-6,7-二甲氧基-3,3-双[6-甲氧基-4'-(萘基)联苯-3-基]合成了-3,13-二氢苯并[ H ]茚满[2,1-F ]铬n-13-Ol)部分.研究了它们的光致变色,电化学和荧光性质.它们显示出比13-丁基-6,7-二甲氧基-3,3-双(4-甲氧基苯基)-3,13-二氢苯并[ H ]茚满[2,1-F ]更快的褪色速率和更大的荧光量子产率] Chromen-13-Ol.此外,它们在溶液和聚甲基丙烯酸甲酯薄膜中均显示出优异的光致变色和荧光性质.另外,循环伏安法测试表明芳族取代基对萘并吡喃衍生物的电化学行为具有显着影响. Doi:10.1007/S10593-018-2366-Z
专利号:WO-2024189634-A1 优先权日:2023-03-13 标 题 :Highly atom economical process for synthesis of novel co-initiator for photo-induced radical polymerisation 发明人:KAPAT DR AJOY; AHMAD ASRAR; MITTAL GARVISHA 权利人:SHIV NADAR INSTITUTION OF EMINENCE DEEMED TO BE UNIV 摘要:The present invention relates to a base catalyzed sequential conjugate addition reaction for the synthesis of a novel and efficient co-initiator for Photo Induced Radical Polymerization. The process comprises synthesis of new co-initiator having 6,5 and 6,6-bicyclic scaffolds as central core. The process comprises reacting thiocarboxylic acid, catechol, thiocatechol, benzodithiol, benzothiocatechol and binol with ketone substrates at room temperature with a base and a solvent to yield the novel co-initiator compound of Formula 3, Formula 5, Formula C and Formula Z.
专利号:WO-2022256490-A9 优先权日:2021-06-03 标题:Improved synthesis of phosphoramidates for the treatment of hepatitis b virus 发明人:LOCKWOOD MARK 权利人:ANTIOS THERAPEUTICS INC 摘要:The synthesis of phosphoramidate prodrugs useful in the treatment of viral infections is disclosed. Specifically, an improved synthesis of phosphoramidate nucleotides useful in the treatment of Hepatitis B virus is disclosed.
专利号:US-11912654-B2 优先权日:2021-09-03 标 题:Process for stereospecific synthesis of vitamin K2 and its novel intermediates 发明人:MEHTA DILIP; SHASHTRI MAYANK; RAJU BNS; SHAH ASHWIN; VORA PARIN; MAHALE UMAKANT 权利人:SYNERGIA LIFE SCIENCES PVT LTD 摘要:The present disclosure relates to a novel process for the synthesis of stereospecific compounds of Vitamin K2 group in general and Vitamin K2-7. The present disclosure further discloses novel intermediates useful in the synthesis of stereospecific Vitamin K2-7. Compounds of the Vitamin K2 group obtained are crystalline and exhibit well defined melting points.
专利号:WO-2023031841-A1 优先权日:2021-09-03 标题:A process for the stereospecific synthesis of vitamin k2 and its intermediates 发明人:MEHTA DILIP; SHASHTRI MAYANK; RAJU BNS; VORA PARIN; MAHALE UMAKANT 权利人:SYNERGIA LIFE SCIENCES PVT LTD 摘要:The present disclosure relates to a novel process for the synthesis of stereospecific compounds of Vitamin K2 group in general and Vitamin K2-7, in particular. It also discloses novel intermediates useful in the synthesis of stereospecific Vitamin K2-7. Compounds of the Vitamin K2 group obtained are crystalline and exhibit well defined melting points.
专利号:US-9745281-B2 优先权日:2013-02-14 标 题 :Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds 发明人:BOITEAU JEAN-GUY 权利人:GALDERMA RES & DEV 摘要:A method is described for the synthesis of 4-(heterocycloalkyl)-benzene-1,3-diol compounds of general formulae (I) and (II): n nwherein X can be an oxygen atom or a sulphur atom. Also described, is a method for the synthesis of the reactive intermediates of general formula (7a) or (7b)n n nNovel compounds as synthesis intermediates are also described.
专利号:US-8901352-B2 优先权日:2011-01-13 标题 :Method for the synthesis of rasagiline 发明人:REIS ÖMER; KOYUNCU HASAN; ESIRINGU ILKER; SAHIN YASEMIN; GULCAN H OZAN 权利人:REIS ÖMER; KOYUNCU HASAN; ESIRINGU ILKER; SAHIN YASEMIN; GULCAN H OZAN; NOBEL ILAÇ SANAYII VE TICARET A S 摘要:We have developed a new method for the synthesis of Rasagiline (Formula 1) based on the alkylation of trifluoroacetyl protected aminoindan. This protection enabled us to carry out an alkylation of aminoindan with a high yield and purity under very mild conditions with a wide range of reaction conditions and reagent selection. Considering the ease, purity and high yields of introducing and removal of the trifluoroacetyl group, this approach is a highly practical and economical way for the synthesis of rasagiline or its pharmaceutically acceptable salts.